Perturbations du comportement secondaires aux troubles neurocognitifs (SCPD) : Évaluation et prise en charge globale #070

Mintzer, J. E., Tune, L. E., Breder, C. D., Swanink, R., Marcus, R. N., McQuade, R. D., & Forbes, A. (2007). Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. Am J Geriatr Psychiatry, 15(11), 918-931. doi: 10.1097/JGP.0b013e3181557b47 http://www.ncbi.nlm.nih.gov/pubmed/17974864